RxDoctor Payments Data

Jeffery Bowman, DO

Family Medicine · Grand Junction, CONPI 1013950435

Payments from drug & device makers

$292in general payments, 2019–2025

Across 16 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$129
  • Pfizer$55
  • Abbott$23
  • Merck$22
  • Axsome Therapeutics, Inc.$20
  • Amgen$16
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$292100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)7$129
Pfizer3$55
Abbott1$23
Merck1$22
Axsome Therapeutics, Inc.1$20
Amgen1$16
Exact Sciences1$15
AstraZeneca1$11

How this compares

$292 in reported general payments places this provider in the 60th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$84,763
Medicare patients
166
Services billed
5,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban33$35,870
EliquisApixaban31$32,655
JardianceEmpagliflozin30$26,148
OzempicSemaglutide13$21,986
TrintellixVortioxetine Hydrobromide18$12,874
JanuviaSitagliptin Phosphate17$12,622
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog30$10,120
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,233
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,338
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,067
Albuterol Sulfate HfaAlbuterol Sulfate76$2,422
Celecoxib69$2,210
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,053
Gabapentin144$2,004
Levothyroxine Sodium231$1,953

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$32,65531 claims
MerckJanuvia$22$12,62217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Grand Junction

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →